It's Time to Flip the Script on Blood Testing
Jun 02, 2023•9 min•Season 2Ep. 7
Episode description
In this episode of Let's Talk Medtech, Babson Diagnostics CEO David Stein discusses the company's progress toward commercialization. Babson has developed a model for diagnostic blood testing that maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods. Babson also uses a proprietary blood collection device to collect the sample at a participating pharmacy, then the sample is processed back at Babson's labs.
For the best experience, listen in Metacast app for iOS or Android
